Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare Beneficiaries | Zendy

Niteesh K. Choudhry | Zendy; Amanda R. Patrick | Zendy; Elliott M. Antman | Zendy; Jerry Avorn | Zendy; William H. Shrank | Zendy

Open Access

Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare Beneficiaries

Author(s) -

Niteesh K. Choudhry,

Amanda R. Patrick,

Elliott M. Antman,

Jerry Avorn,

William H. Shrank

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.735605

Subject(s) - medicine , myocardial infarction , medicare part d , medical prescription , pharmacotherapy , prescription drug , quality adjusted life year , aspirin , intensive care medicine , emergency medicine , cost effectiveness , pharmacology , risk analysis (engineering)

Effective therapies for the secondary prevention of coronary heart disease-related events are significantly underused, and attempts to improve adherence have often yielded disappointing results. Elimination of patient out-of-pocket costs may be an effective strategy to enhance medication use. We sought to estimate the incremental cost-effectiveness of providing full coverage for aspirin, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins (combination pharmacotherapy) to individuals enrolled in the Medicare drug benefit program after acute myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research